Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

BBNX

Beta Bionics Inc

Feb 03 • 04:00PM ET

22.75

Dollar change -1.06
Percentage change -4.45	%

Healthcare • Medical Devices • USA • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	42.86M	Perf Week	-
Market Cap	975.06M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Income	-	PEG	-	EPS next Q	-	Inst Own	31.73%	Short Float	-	Perf Quarter	-
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Book/sh	-5.34	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf Year	-
Cash/sh	1.42	P/C	16.01	EPS next 5Y	-	ROE	-	52W Range	22.00 - 24.50	Perf YTD	-3.72%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-7.14%	Beta	-
Dividend TTM	-	Quick Ratio	3.99	Sales past 5Y	6601.12%	Gross Margin	-	52W Low	3.41%	ATR (14)	1.94
Dividend Ex-Date	-	Current Ratio	4.62	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	-	Volatility	- -
Employees	277	Debt/Eq	0.22	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.18	EPS Q/Q	-	Payout	-	Rel Volume	0.17	Prev Close	23.81
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	4.03M	Price	22.75
SMA20	-2.76%	SMA50	-2.76%	SMA200	-2.76%	Trades		Volume	693,769	Change	-4.45%

Jan-31-25 05:56PM	Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
06:34AM	Beta Bionics raises $204M in IPO (MedTech Dive)
Jan-30-25 12:55PM	Beta Bionics raises $204m to kickstart medtech IPO season (Medical Device Network)
Jan-29-25 10:34PM	Beta Bionics Announces Pricing of Upsized $204 Million Initial Public Offering (GlobeNewswire)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Mensinger Mike	Chief Product Officer	Jan 31 '25	Buy	17.00	33,350	566,950	59,019	Feb 03 08:30 PM
Mensinger Mike	Chief Product Officer	Jan 31 '25	Sale	17.00	13	221	25,669	Feb 03 08:30 PM
Wellington Hadley Harbor Aggre	10% Owner	Jan 31 '25	Buy	17.00	1,000,000	17,000,000	3,901,599	Feb 03 04:49 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BBNX

Beta Bionics Inc

Upgrade your FINVIZ experience